Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Philippe Collet

Showing results (131-140 of 376) with videos related to

Pageof 38
Sort By:
European Heart Journal|January 26, 2007
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-upGilles Montalescot, David Antoniucci, Adnan Kastrati, et al.
Circulation. Cardiovascular Interventions|October 6, 2011
CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patientsJean-Sébastien Hulot, Jean-Philippe Collet, Guillaume Cayla, et al.
Journal of the American College of Cardiology|July 13, 2010
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysisJean-Sébastien Hulot, Jean-Philippe Collet, Johanne Silvain, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 13, 2003
Prognosis of moderate coronary artery lesions in heart transplant patientsCharles Edouard Luyt, Gérard Drobinski, Richard Dorent, et al.
Thrombosis and Haemostasis|January 6, 2018
Amino-Fucoidan as a Vector for rtPA-Induced Fibrinolysis in Experimental Thrombotic EventsRadouane Ghebouli, Stephane Loyau, Murielle Maire, et al.
Archives of Internal Medicine|December 12, 2007
Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trialsRaphaelle Dumaine, Maria Borentain, Osmund Bertel, et al.
Archives of Cardiovascular Diseases|June 29, 2013
Anaemia to predict outcome in patients with acute coronary syndromesPierre Vladimir Ennezat, Sylvestre Maréchaux, Claire Pinçon, et al.
Platelets|September 23, 2016
Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trialsVincent Roule, Moaad Agueznai, Rémi Sabatier, et al.
American Heart Journal|June 15, 2018
Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trialJean-Philippe Collet, Sergio Berti, Angel Cequier, et al.
Archives of Cardiovascular Diseases|June 27, 2015
Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarctionMathieu Kerneis, Johanne Silvain, Jérémie Abtan, et al.
Pageof 38

Showing results (131-140 of 376) with videos related to

Sort By:
Pageof 38
European Heart Journal|January 26, 2007
Abciximab in primary coronary stenting of ST-elevation myocardial infarction: a European meta-analysis on individual patients' data with long-term follow-upGilles Montalescot, David Antoniucci, Adnan Kastrati, et al.
Circulation. Cardiovascular Interventions|October 6, 2011
CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patientsJean-Sébastien Hulot, Jean-Philippe Collet, Guillaume Cayla, et al.
Journal of the American College of Cardiology|July 13, 2010
Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysisJean-Sébastien Hulot, Jean-Philippe Collet, Johanne Silvain, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 13, 2003
Prognosis of moderate coronary artery lesions in heart transplant patientsCharles Edouard Luyt, Gérard Drobinski, Richard Dorent, et al.
Thrombosis and Haemostasis|January 6, 2018
Amino-Fucoidan as a Vector for rtPA-Induced Fibrinolysis in Experimental Thrombotic EventsRadouane Ghebouli, Stephane Loyau, Murielle Maire, et al.
Archives of Internal Medicine|December 12, 2007
Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trialsRaphaelle Dumaine, Maria Borentain, Osmund Bertel, et al.
Archives of Cardiovascular Diseases|June 29, 2013
Anaemia to predict outcome in patients with acute coronary syndromesPierre Vladimir Ennezat, Sylvestre Maréchaux, Claire Pinçon, et al.
Platelets|September 23, 2016
Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trialsVincent Roule, Moaad Agueznai, Rémi Sabatier, et al.
American Heart Journal|June 15, 2018
Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: The randomized ATLANTIS trialJean-Philippe Collet, Sergio Berti, Angel Cequier, et al.
Archives of Cardiovascular Diseases|June 27, 2015
Platelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarctionMathieu Kerneis, Johanne Silvain, Jérémie Abtan, et al.
Pageof 38